Search

everythinglearnresearchcommunity

for

Search:↓

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

PROTACs show promise in cancer treatment by effectively degrading specific harmful proteins.

MVP treatment is effective and safe for recurrent breast cancer.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

Dutasteride and minoxidil helped regrow hair in a woman with breast cancer.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

The treatment combination is effective and generally safe for lung cancer.

The combination treatment showed a higher response rate but no significant survival benefits.

Chemotherapy causes complex changes in hair follicle cells that can lead to hair loss.

Doctors should actively prevent and treat skin side effects in cancer patients to keep them on the best medication and reduce discomfort.

Fenoterol treatment causes increased hair growth due to higher metabolism in hair follicles, not hormones.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Some patients' hair grew back black and white after chemotherapy.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

Cepharanthine helps reduce cell aging caused by the cancer drug Doxorubicin by boosting cell cleanup processes.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Antibody drug conjugates show promise in targeting cancer cells while reducing harm to healthy cells.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Longer immunotherapy treatment may improve outcomes for Merkel cell carcinoma patients.

The new delivery system improved raloxifene's skin absorption and effectiveness against cancer cells.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.